To clarify the characteristics of IFI30 in gliomas, we first analysed its expression level in the CGGA and TCGA data sets stratified according to the tumour grade, isocitrate dehydrogenase (IDH) mutation status, and 1p/19q codeletion status. The gene discussed is IFI30; the disease is central nervous system cancer.